Teva Pharmaceuticals, one of the largest generic pharmaceutical companies has filed a patent infringement lawsuit against the Canada based pharmaceutical company Apotex Inc. The law suit was filed before the US District Court for the District of New Jersey. This law suit was filed after Apotex Inc. applied to the US Food and Drug Administration to market a generic version of Azilect, Teva's brand treatment for Parkinson's disease. Reports state that Teva claims Azilect's US patents to be valid until February 2017. The US patents were granted in 1995 to Azilect's inventors, and Teva owns the rights to the drug under an agreement with the Technion - Israel Institute of Technology.
Image from here
0 comments:
Post a Comment